A Study of Avutometinib for People With Solid Tumor Cancers
Status:
Recruiting
Trial end date:
2029-10-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether avutometinib is a safe treatment for
advanced or recurrent solid tumor cancers in children and young adults. Researchers will look
for the highest dose of avutometinib that is safe and cause few or mild side effects.